Cruise ship stocks came under pressure on Tuesday, as the highly contagious delta variant fueled a surge in COVID-19 case counts around the world. As of 3 p.m. EDT today, shares of Carnival (NYSE: CCL) (NYSE: CUK), Royal Caribbean (NYSE: RCL), and Norwegian Cruise Line Holdings (NYSE: NCLH) were down 2%, 3%, and 3%, respectively.
The seven-day average of daily COVID cases recently rose above 72,000, according to the Centers for Disease Control and Prevention (CDC), exceeding last summer's peak. Hospital admissions and deaths also increased at an alarming rate.
"While we desperately want to be done with this pandemic, COVID-19 is clearly not done with us," the CDC director, Dr. Rochelle Walensky, said during a White House briefing on Monday.
Cruise ship stocks fell on Tuesday. Image source: Getty Images.
Amid mounting coronavirus case counts, cruise lines are beginning to resume sailing. Perhaps unsurprisingly, COVID outbreaks have already occurred on their ships. Some cruise operators are requiring passengers to get tested for the virus in an effort to keep their customers safe, but the added cost and inconvenience is no doubt turning some would-be passengers away.
Unfortunately, delta and other emerging coronavirus strains are likely to continue to hamper the cruise lines' recovery until their spread is contained. Investors can expect to receive an update on the current state of the cruise industry and its latest plans to combat the coronavirus when Royal Caribbean conducts its second-quarter conference call tomorrow at 10 a.m. EDT.
10 stocks we like better than Royal Caribbean
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Royal Caribbean wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 7, 2021
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.